Not Signed In -
Obesity |
Overweight |
Clinical Trial: A 2-Year Study of an Investigational Drug in Obese Patients
This study is no longer recruiting patients.
|
Purpose
This is a 2-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Obesity | | Phase II Phase III |
MedlinePlus related topics: Obesity
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Obese men and nonpregnant women at least 18 years of age with a specific body mass index (height and weight ratio) required by the study
Exclusion Criteria:
- Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)
More Information
Study ID Numbers: 2004_030
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 23, 2004
ClinicalTrials.gov Identifier: NCT00092859
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 23, 2004
ClinicalTrials.gov Identifier: NCT00092859
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
email this page
print this page
bookmark this page
feedback on this page
